Octreotide

Octreotide is a medication used to treat various medical conditions. It works by slowing down the release of hormones from certain glands. It's often used to manage tumors that produce too much hormone, like some types of cancer. It can also help control blood sugar levels in diabetes and treat low blood pressure.

Brand names:Sandostatin
Medication

What people taking Octreotide report

Every report comes from a Lived member, sent anonymously.

Have you tried Octreotide for Acromegaly?

NameHow it went

About Octreotide

What It's For

Octreotide is a prescription medicine that reduces the body's overproduction of certain hormones. It is sold as Sandostatin (a short-acting injection, also available as a generic), Sandostatin LAR Depot (a long-acting monthly injection) and Mycapssa (capsules taken by mouth). Its main approved use is acromegaly, a condition in which a usually benign pituitary tumor releases too much growth hormone, gradually enlarging the hands, feet and facial features and straining the heart and joints. Surgery is usually the first treatment; octreotide is used when surgery or radiation has not brought hormone levels under control or is not an option. The injections are also approved to control the severe diarrhea and flushing caused by carcinoid tumors (a type of neuroendocrine tumor that releases serotonin and similar substances) that have spread, and the profuse watery diarrhea caused by VIPomas, rare pancreatic tumors that release a hormone called vasoactive intestinal peptide. For these tumors, the approved purpose is symptom control: the product labels do not establish that Sandostatin or Sandostatin LAR Depot shrinks the tumor or slows its growth. Mycapssa is approved only for acromegaly, as long-term maintenance in people who have already responded to and tolerated octreotide or lanreotide (a similar injected medicine). In hospitals, doctors also give octreotide into a vein for some uses outside its label, most commonly to help control bleeding from enlarged veins in the esophagus in people with liver cirrhosis.

How It Works

Somatostatin is a natural hormone that acts as a brake on the release of other hormones. Octreotide is a lab-made version that lasts much longer in the body and works more strongly. In acromegaly, it reduces growth hormone release from the pituitary, which in turn lowers IGF-1 (insulin-like growth factor 1), the substance that carries out most of growth hormone's effects on tissues. In carcinoid syndrome and VIPomas, it reduces the release of serotonin, vasoactive intestinal peptide and other gut hormones that drive diarrhea and flushing. The same braking effect explains many of its side effects. Octreotide also slows the gallbladder, reduces the release of pancreatic digestive enzymes and shifts the balance of insulin and glucagon, the hormones that control blood sugar.

Dosage & Administration

Treatment usually starts with the short-acting injection, given under the skin two to four times a day, so the care team can see whether it works and how well it is tolerated. Many people learn to inject themselves at home. Rotating injection sites helps reduce soreness. In hospitals, the short-acting form can also be given into a vein. People who respond well can usually switch to Sandostatin LAR Depot, an injection into the buttock muscle every 4 weeks. A trained health professional prepares and gives it; it is never injected under the skin or into a vein. With carcinoid tumors and VIPomas, symptoms often flare from time to time even when control is good overall, and short-acting injections may be added for a few days during these periods. Mycapssa capsules are taken twice a day on an empty stomach with a glass of water, at least 1 hour before or 2 hours after a meal. They must be swallowed whole, not crushed or chewed. In every form, the dose is adjusted gradually based on symptoms and blood tests rather than set once.

Side Effects

Nausea, diarrhea or loose stools, abdominal discomfort, bloating and gas are common, especially in the first weeks, and often ease with time. Injections under the skin can sting or cause redness. Some people notice pale, greasy or foul-smelling stools, which can mean fat is not being absorbed well; this is worth mentioning because the care team can check for and treat it. Gallstones and gallbladder sludge are the best-known long-term effect. In studies, about half of people treated for a year or longer developed them, though most never had symptoms. Pain in the upper right or center of the abdomen, pain spreading to the back or shoulder, or yellowing of the skin or eyes should be reported to the doctor right away, since these can signal a gallstone blocking a duct or inflammation of the gallbladder or pancreas. Octreotide can also slow the heart rate. A heartbeat that feels slow or irregular, or new dizziness or faintness, deserves a prompt call. Over months, it can lower thyroid hormone production; tiredness, feeling cold, a puffy face or dry skin are reasons to have thyroid levels checked.

Interactions & Warnings

Octreotide can push blood sugar either up or down. People with diabetes, especially those using insulin or other glucose-lowering medicines, usually need more frequent glucose checks when starting octreotide or changing the dose, and their diabetes treatment may need adjusting. Because it slows the heart, medicines that also lower heart rate, such as beta-blockers (blood pressure and heart medicines like metoprolol), may need dose changes. People with existing heart rhythm problems or heart failure need closer monitoring. Octreotide can lower blood levels of cyclosporine, an anti-rejection medicine, which can risk transplant rejection. For people with neuroendocrine tumors who receive lutetium Lu 177 dotatate, a radioactive treatment that targets the same receptors octreotide binds to, octreotide is paused so it does not block the therapy: the monthly injection is stopped at least 4 weeks before each lutetium dose, and short-acting octreotide (which may be used in between for symptoms) at least 24 hours before. Mycapssa has some extra interactions of its own. Acid-reducing medicines (proton pump inhibitors such as esomeprazole, H2 blockers such as famotidine (Pepcid), and antacids) can reduce how much is absorbed. It may also make combined birth control pills less reliable, so a non-hormonal or backup method is recommended. In women with acromegaly, bringing hormone levels under control can restore fertility, so pregnancy is possible even after a long period without it. Information on octreotide during pregnancy is limited; anyone pregnant or planning pregnancy should discuss it with their specialist.

What to Expect

Octreotide controls hormone excess rather than curing its cause, so for most people it is a long-term treatment. In carcinoid syndrome and VIPomas, the doses are adjusted until diarrhea and flushing are controlled, and occasional flare-ups can still happen. In acromegaly, success is measured mainly by blood tests: growth hormone and IGF-1 are checked every few weeks while the dose is adjusted, aiming to bring IGF-1 back into the normal range, then less often once stable. Regular follow-up usually includes blood sugar, thyroid tests and vitamin B12 levels (octreotide can reduce B12 absorption over time), and sometimes an ultrasound of the gallbladder or a heart rhythm check. People who had radiation for acromegaly may have octreotide paused for a few weeks each year to see whether the disease is still active. If octreotide does not control the condition well enough, the specialist can consider a related medicine such as lanreotide or a different type of treatment.

Questions to Ask Your Doctor

  1. 1.Which form of octreotide makes sense for me, and could I move to the monthly injection or capsules once my dose is settled?
  2. 2.What results should we look for, and which blood tests or symptoms will show whether it is working?
  3. 3.How will we watch for gallstones, heart rhythm changes and blood sugar problems, and what should make me call you?
  4. 4.Do any of my current medicines, including diabetes, heart, acid-reducing or birth control medicines, need to change?
  5. 5.How long am I likely to stay on octreotide, and what are the alternatives if it stops working?

Last reviewed • Oct 2026

Educational content, not medical advice.